Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Syphilis of lung and bronchus
Summary
Syphilis of lung and bronchus is a late-stage manifestation of syphilis infection, occurring years after initial exposure, that specifically affects the lung and bronchial tissues. It results from untreated or inadequately treated earlier stages of the disease and can involve inflammatory or destructive changes in these respiratory structures, potentially leading to functional impairment or complications.
Causes
Syphilis of lung and bronchus is caused by the bacterium Treponema pallidum. It develops when the infection progresses untreated through primary, secondary, and latent stages, allowing the bacteria to invade and damage lung and bronchial tissues in the tertiary phase. The condition arises due to the persistence of the infection and the body's immune response to the bacteria over time.
Risk Factors
- Untreated or inadequately treated syphilis
- Prolonged latency period without medical intervention
- Immune system compromise (e.g., HIV infection)
- High-risk sexual behaviors or exposure to infected individuals
Symptoms
- Respiratory: cough, hemoptysis (blood in sucus), or dyspnea (shortness of breath)
- General: fatigue, weight loss, or low-grade fever
- Localized: chest pain or wheezing due to bronchial involvement
Diagnosis
Diagnosis involves serologic testing for syphilis antibodies (e.g., RPR, VDRL) to confirm infection, along with specialized tests based on respiratory symptoms. Imaging (e.g., chest X-ray, CT scan) or bronchoscopy may be used to assess lung and bronchial involvement, and tissue biopsy may be performed to identify characteristic lesions.
Treatment Options
Treatment typically involves intramuscular or intravenous penicillin, the preferred antibiotic for syphilis. The dosage and duration depend on the stage and severity of the infection. Follow-up serologic testing is recommended to ensure treatment efficacy. Adjunct therapies may address specific symptoms or complications.
Prognosis and Follow-Up
With appropriate antibiotic treatment, the prognosis for syphilis of lung and bronchus is generally favorable, though residual damage may persist. Regular follow-up serologic testing and clinical monitoring are essential to confirm resolution and detect any recurrence. Long-term outcomes depend on the extent of tissue damage prior to treatment.
Complications
- Respiratory failure due to severe lung involvement
- Secondary bacterial infections in damaged tissues
- Progression to other late-stage syphilis manifestations if untreated
Lifestyle & Prevention
- Practice safe sex to reduce exposure risk
- Seek prompt treatment for early syphilis stages
- Regular screening for high-risk individuals
- Avoid sharing needles or other exposure routes
When to Seek Professional Help
Seek medical attention if you experience persistent respiratory symptoms (e.g., cough, hemoptysis), unexplained weight loss, or fever, especially if you have a history of syphilis or high-risk exposure. Early evaluation is critical to prevent progression and complications.
Tips for Medical Coders
When coding for syphilis of lung and bronchus, use ICD-10-CM code A52.72. Ensure documentation supports the specific respiratory involvement, including clinical findings, diagnostic tests, and treatment. Verify that the code aligns with the patient's clinical presentation and that no other late syphilis codes apply.
A52.72 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.